SCHARP data shows longer nevirapine treatment reduces infection by half for babies with HIV-infected mothers, 75 percent for infants of untreated moms
March 14, 2011
Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented March 2 at the Retroviruses and Opportunistic Infections conference in Boston.
VIDI’s Elizabeth Brown studies mother-to-child transmission of HIV and more to make a difference in peoples’ lives
June 22, 2009
| By Rachel Tompa
From mother-to-child transmission of HIV to coronary artery lesions, Dr. Elizabeth Brown of the Fred Hutchinson Cancer Research Center loves a statistical challenge. And the more uncertain, the better—that’s where she believes good statistics can really make a difference.